Dagondon, Julie S.
HRN: 22-89-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/11/2023
CEFUROXIME 1.5GM (VIAL)
07/11/2023
07/18/2023
IV
1.5g
Q8hrs
S/P Parotidectomy
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes